Estée Lauder unveils ‘breakthrough’ platform to accelerate skin science and longevity innovations

By Lollie Hancock | Published: 9-Nov-2026

Estée Lauder Companies’ new Mastering Skin Longevity platform claims to look beyond the study of individual hallmarks of ageing by placing the focus on the ‘master regulators of skin longevity’, helping to advance skin science for brands The Ordinary, Clinique, La Mer and Dr.Jart+

Estée Lauder Companies (ELC) has unveiled a new “breakthrough” scientific platform it says will advance “the next era of skin science” and longevity innovations.

The beauty giant’s Mastering Skin Longevity platform claims to look beyond the study of individual hallmarks of ageing by placing the focus on the “master regulators of skin longevity” – interconnected biological pathways and proteins that influence multiple hallmarks at once.

The platform will serve as a shared scientific foundation for ELC’s brand portfolio, including The Ordinary, Clinique and Dr.Jart+.

ELC revealed Mastering Skin Longevity at the China International Import Expo in Shanghai, China, which took place from 5 to 10 November.

Alongside the new platform, ELC has also introduced a comprehensive scientific white paper outlining its perspective on the evolution of skin longevity science and the role of the master regulators.

“Mastering skin longevity reflects how we are advancing the next era of skin science and innovation across our brand portfolio,” said Stéphane de La Faverie, ELC’s President and CEO.

“Building on 80 years of scientific leadership and two decades of pioneering longevity research, we are translating breakthrough scientific discoveries into products that consumers trust and love.

“We are proud to introduce this platform in China, a market at the forefront of scientific and consumer innovation.”

Brands across ELC’s portfolio will continue to explore longevity through different areas of focus.

ELC’s own brand Estée Lauder will place focus on sirtuin biology and epigenetics, while La Mer will hold leadership in cellular energy and visible skin renewal.

Clinique, will continue to take a clinically proven approach to visible signs of ageing and skin resilience, while Deciem’s The Ordinary will focus on turning evidence-based research into age-supporting ingredients and technologies.

René Lammers, Executive VP and Chief Research & Innovation Officer, ELC, added: “The hallmarks of ageing help us understand what changes in skin over time.

“The master regulators help us investigate the biological systems that influence those changes.

“By studying these systems together, we can create a more integrated foundation for discovery, and identify new opportunities across ingredients, technologies, formulations and products.”